BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9493588)

  • 61. The effect of s-nitroso-glutathione on platelet and leukocyte function during experimental extracorporeal circulation.
    Adrian K; Skogby M; Friberg LG; Mellgren K
    Artif Organs; 2003 Jun; 27(6):570-5. PubMed ID: 12780512
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hematological problems during the use of cardiac assist devices: clinical experiences in Japan.
    Tanaka K; Sato T; Kondo C; Yada I; Yuasa H; Kusagawa M; Nasu M; Okada Y; Shomura T
    Artif Organs; 1992 Apr; 16(2):182-8. PubMed ID: 10078242
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nafamostat as anti-coagulant for membrane plasmapheresis in high bleeding risk patients.
    Kinugasa E; Akizawa T; Nakashima Y; Wakasa M; Koshikawa S
    Int J Artif Organs; 1992 Oct; 15(10):595-600. PubMed ID: 1428207
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anticoagulation during use of a left ventricular assist device.
    Takahama T; Kanai F; Onishi K
    ASAIO J; 2000; 46(3):354-7. PubMed ID: 10826751
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Application of a prostacyclin analogue (PG) and protease inhibitor (FUT) as anticoagulants with an LVAD system.
    Takahama T; Kanai F; Hiraishi M; Onishi K; Yamazaki Z; Furuse A; Asano K; Yoshitake T; Kazama M
    ASAIO Trans; 1986; 32(1):253-7. PubMed ID: 3535842
    [No Abstract]   [Full Text] [Related]  

  • 66. [Inhibition of platelet aggregation and prevention of endotoxin-induced DIC by a protease inhibitor, FUT-175, in rats].
    Yoshikawa T; Murakami M; Furukawa Y; Onodera H; Yoshida N; Ueda M; Kato H; Takemura S; Sugino S; Kondo M
    Masui; 1984 Apr; 33(4):397-402. PubMed ID: 6471360
    [No Abstract]   [Full Text] [Related]  

  • 67. Inhibitory effects of newly synthesized active center-directed trypsin-like serine protease inhibitors on the complement system.
    Ueda N; Midorikawa A; Ino Y; Oda M; Nakamura K; Suzuki S; Kurumi M
    Inflamm Res; 2000 Jan; 49(1):42-6. PubMed ID: 10778920
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Inhibitory effect of nafamostat mesilate (FUT-175) on O2- production in rat polymorphonuclear leucocytes].
    Oda M; Ogihara M; Sato T; Kurumi M; Iwaki M
    Nihon Yakurigaku Zasshi; 1986 May; 87(5):521-6. PubMed ID: 3015753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prophylactic administration of tranexamic acid preserves platelet numbers during extracorporeal circulation in rabbits.
    Plötz FB; van Oeveren W; Aloe LS; Riley MK; Hultquist KA; Bartlett RH; Wildevuur CR
    ASAIO Trans; 1991; 37(3):M416-7. PubMed ID: 1751215
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Activation of blood coagulation in extracorporeal circulation].
    Nowak G
    Wien Klin Wochenschr; 1996; 108 Suppl 1():9-14. PubMed ID: 8686324
    [No Abstract]   [Full Text] [Related]  

  • 71. Anticoagulation with defibrase during prolonged extracorporeal circulation in the dog.
    Berglin E; Svalander ; Teger-Nilsson A-C ; William-Olsson G
    Scand J Thorac Cardiovasc Surg; 1976; 10(3):225-30. PubMed ID: 1006222
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative study on the in vitro effectiveness of antithrombotic agents.
    Pâques EP; Römisch J
    Thromb Res; 1991 Oct; 64(1):11-21. PubMed ID: 1776137
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Deleterious effects of complement activation on the lungs during extracorporeal circulation and its inhibition by FUT-175.
    Miyamoto Y; Matsuda H; Kawashima Y
    J Biomater Appl; 1989 Jul; 4(1):56-68. PubMed ID: 2664117
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical evaluation of nafamstat mesilate (FUT 175). A new anticoagulant for plasmapheresis.
    Hosokawa S; Oyamaguchi A; Yoshida O
    ASAIO J; 1992; 38(1):59-60. PubMed ID: 1554918
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chronic threshold testing of implantable cardioverter defibrillators does not increase coagulation activity or platelet activation.
    Smolich JJ; Yates LA; Malan E; Gan TE; Harper RW; Alison JF; Peverill RE
    Pacing Clin Electrophysiol; 2002 Nov; 25(11):1594-8. PubMed ID: 12494617
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Comparative studies of the adsorption behavior of plasma proteins to heparin-coated surfaces].
    Wendel HP; Weber N; Ziemer G
    Biomed Tech (Berl); 2000 Oct; 45(10):282-7. PubMed ID: 11085010
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical evaluation of a new synthetic protease inhibitor in open heart surgery. Effect on plasma serotonin and histamine release and blood conservation.
    Miyamoto Y; Nakano S; Kaneko M; Takano H; Matsuda H
    ASAIO J; 1992; 38(3):M395-8. PubMed ID: 1281015
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Attenuation of hepatic ischemia and reperfusion injury by serine protease inhibitor, FUT-175, in dogs.
    Horiuchi H; Suzuki T; Taniguchi M; Magata S; Jin MB; Ishikawa H; Ogata K; Shimamura T; Furukawa H; Todo S
    Transplant Proc; 2001; 33(1-2):848. PubMed ID: 11267095
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacodynamics of FUT-175 anticoagulant in adsorbent plasma perfusion.
    Yamazaki Z; Hiraishi M; Kanai F; Takahama T; Idezuki Y; Inoue N
    ASAIO Trans; 1989; 35(3):567-9. PubMed ID: 2688721
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Behavior of blood platelets in extracorporeal circulation].
    Grundman J
    Pol Przegl Chir; 1973 Jan; 45(1):15-21. PubMed ID: 4688776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.